Work

Indirect treatment comparison of belantamab mafodotin + pomalidomide + dexamethasone versus comparator regimens in lenalidomide-exposed relapsed/refractory multiple myeloma: A network meta-analysis

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7567

Authors: Joshua Richter, Meral Beksac, Alessandro Corso, Ollie Schofield, Dani Olivier, Leanne Cooper, Owen Harrison, Jacopo Bitetti, Benga Kazeem, Alex Bates, Natalie Boytsov, Simon McNamara, Adil Merchant, Connor Lloyd, Christina-Jane Crossman-Morgan, Nicholas Meader, Molly Purser, Nick Ballew

Institutions: Mount Sinai Hospital, Istinye University, Azienda Ospedaliera Ospedale Civile di Legnano, Aziende Socio Sanitarie Territoriale Ovest Milanese, GlaxoSmithKline (Switzerland), RWE (United Kingdom), GlaxoSmithKline (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417006242

Cites:

Cited by:

Related to: